Immunoassays

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.

Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum.

Cardiolipin-GM is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative detection of IgG and /or IgM vantibodies against cardiolipin in human serum.

β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2-glycoproteinI highly purified from human plasma for the separate quantitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum.

Phospholipid-Screen-GM is a solid phase enzyme immunoassay for the separate quantitative detection of IgG and/or IgM antibodies against phospholipids in human serum. Each well is coated with highly purified bovine cardiolipin + ß2-glycoprotein I, phosph.

ANCA Pro is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) and proteinase 3 (PR3) from human peripheral blood polymorphnuclear cells and native human Cathepsin G, Elastase, Lactoferrin, Lysozym and BPI.

PR3 sensitive is a solid phase enzyme immunoassay employing highly purified native human proteinase 3 (PR3) from human neutrophil granulocytes for the quantitative detection of antibodies against proteinase 3 in human serum.

MPO is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) from human peripheral blood polymorphnuclear cells for the quantitative detection of antibodies against MPO in human serum.